Cargando…

Pituitary Adenylate Cyclase Activating Peptide and Post-traumatic Stress Disorder: From Bench to Bedside

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide with isoforms consisting of either 27 or 38 amino acids. PACAP is encoded by the adenylate cyclase activating peptide gene, ADCYAP1, in humans and the highly conserved corresponding rodent gene, Adcyap1. PACAP is known to r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riser, Manessa, Norrholm, Seth Davin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295898/ https://www.ncbi.nlm.nih.gov/pubmed/35865299 http://dx.doi.org/10.3389/fpsyt.2022.861606

Ejemplares similares

Pituitary adenylate cyclase activating polypeptide and migraine
por: Zagami, Alessandro S, et al.
Publicado: (2014)

Stress-related disorders, pituitary adenylate cyclase—activating peptide (PACAP)ergic system, and sex differences
por: Ramikie, Teniel S., et al.
Publicado: (2016)

Pituitary Adenylate Cyclase-Activating Polypeptide: A Promising Neuroprotective Peptide in Stroke
por: Fang, Yuanjian, et al.
Publicado: (2020)

Pituitary Adenylate Cyclase-Activating Polypeptide in Learning and Memory
por: Gilmartin, Marieke R., et al.
Publicado: (2021)

Role of pituitary adenylate cyclase‐activating polypeptide in modulating hypothalamic‐pituitary system
por: Oride, Aki, et al.
Publicado: (2018)

Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
por: Cardoso, João C. R., et al.
Publicado: (2020)

Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death
por: Horvath, Gabriella, et al.
Publicado: (2022)

Conditioned Fear Associated Phenotypes as Robust, Translational Indices of Trauma-, Stressor-, and Anxiety-Related Behaviors
por: Briscione, Maria Anne, et al.
Publicado: (2014)

Pituitary Adenylate Cyclase Activating Peptide (PACAP) Participates in Adipogenesis by Activating ERK Signaling Pathway
por: Arsenijevic, Tatjana, et al.
Publicado: (2013)

Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
por: Atlasz, Tamas, et al.
Publicado: (2018)

Antibacterial properties of the pituitary adenylate cyclase-activating polypeptide: A new human antimicrobial peptide
por: Debbabi, Somia, et al.
Publicado: (2018)

New Evidence for the Role of Pituitary Adenylate Cyclase-Activating Polypeptide as an Antimicrobial Peptide in Teleost Fish
por: Velázquez, Janet, et al.
Publicado: (2023)

Editorial: Non-invasive brain stimulation in psychiatric disorders: From bench to bedside
por: Liang, Chih-Sung, et al.
Publicado: (2023)

Distribution and protective function of pituitary adenylate cyclase-activating polypeptide in the retina
por: Nakamachi, Tomoya, et al.
Publicado: (2012)

Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases
por: Lee, Eun Hye, et al.
Publicado: (2014)

Corrigendum: Tracing the Origins of the Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP)
por: Cardoso, João C. R., et al.
Publicado: (2020)

Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraine
por: Ashina, Messoud
Publicado: (2022)

Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis
por: Christensen, Casper Emil, et al.
Publicado: (2022)

Increased pituitary adenylate cyclase-activating peptide genes expression in the prefrontal cortex in schizophrenia in relation to suicide
por: Slabe, Zala, et al.
Publicado: (2023)

Pituitary Adenylate Cyclase-Activating Polypeptide: A Potent Therapeutic Agent in Oxidative Stress
por: Sadanandan, Nadia, et al.
Publicado: (2021)

The Genetic Intersection of Neurodevelopmental Disorders and Shared Medical Comorbidities – Relations that Translate from Bench to Bedside
por: Plummer, Jasmine T., et al.
Publicado: (2016)

Editorial: Non-invasive brain stimulation in psychiatric disorders: from bench to bedside, volume II
por: Hsu, Chih-Wei, et al.
Publicado: (2023)

Pituitary adenylate cyclase-activating polypeptide (PACAP) in zebrafish models of nephrotic syndrome
por: Eneman, Benedicte, et al.
Publicado: (2017)

Immunomodulatory Effects of the Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide in Acute Toxoplasmosis
por: Figueiredo, Caio Andreeta, et al.
Publicado: (2019)

Lack of Pituitary Adenylate Cyclase–Activating Polypeptide (PACAP) Disturbs Callus Formation
por: Józsa, Gergő, et al.
Publicado: (2019)

Erratum: The Genetic Intersection of Neurodevelopmental Disorders and Shared Medical Comorbidities – Relations that Translate from Bench to Bedside
Publicado: (2016)

Editorial: Recent Advances on the Multimodal Search for Markers of Treatment Response in Affective Disorders: From Bench to Bedside?
por: Schmidt, Frank M., et al.
Publicado: (2019)

Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice
por: Hattori, Satoko, et al.
Publicado: (2012)

Pituitary Adenylate Cyclase-Activating Polypeptide Protects Glomerular Podocytes from Inflammatory Injuries
por: Sakamoto, Kenichi, et al.
Publicado: (2015)

Pituitary Adenylate-Cyclase Activating Polypeptide Regulates Hunger- and Palatability-Induced Binge Eating
por: Hurley, Matthew M., et al.
Publicado: (2016)

Pituitary adenylate cyclase-activating polypeptide expression in peripheral blood mononuclear cells of migraineurs
por: Hou, Lei, et al.
Publicado: (2016)

Beneficial Effects of Crocin against Depression via Pituitary Adenylate Cyclase-Activating Polypeptide
por: Lu, Linyu, et al.
Publicado: (2020)

Neuroprotective Potential of Pituitary Adenylate Cyclase Activating Polypeptide in Retinal Degenerations of Metabolic Origin
por: Gábriel, Robert, et al.
Publicado: (2019)

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus
por: Johnson, Gregory C., et al.
Publicado: (2020)

Potential Therapeutic Role of Pituitary Adenylate Cyclase-Activating Polypeptide for Dry Eye Disease
por: Hirabayashi, Takahiro, et al.
Publicado: (2022)

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases
por: Solés-Tarrés, Irene, et al.
Publicado: (2020)

Neural Mechanisms of Impaired Fear Inhibition in Posttraumatic Stress Disorder
por: Jovanovic, Tanja, et al.
Publicado: (2011)

A narrative review of the epigenetics of post-traumatic stress disorder and post-traumatic stress disorder treatment
por: Cao-Lei, Lei, et al.
Publicado: (2022)

Effects of Combinatorial Treatment with Pituitary Adenylate Cyclase Activating Peptide and Human Mesenchymal Stem Cells on Spinal Cord Tissue Repair
por: Fang, Kuan-Min, et al.
Publicado: (2010)

Pituitary Adenylate Cyclase Activating Peptide Deficient Mice Exhibit Impaired Thymic and Extrathymic Regulatory T Cell Proliferation during EAE
por: Tan, Yossan-Var, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e1fcgq83m19ujb19jj0dkho71o